Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes

Journal of Clinical Microbiology

Volumn 43, Issue 6, 2005, Pages 2920-2922

  Eigner, U ^a   Fahr, A ^a,c   Weizenegger, M ^a   Witte, W ^b  

^a Limbach Laboratory   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c c/o Labor Limbach ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BASE; GLYCOPEPTIDE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; GENOTYPE; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; DNA PROBES; ENTEROCOCCUS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; REAGENT STRIPS; SPECIES SPECIFICITY; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS;

EID: 20444439531     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.6.2920-2922.2005     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. 1999. National nosocomial infections surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27:520-532.
2. Cetinkaya, Y., P. Falk, and C. G. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
3. Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
4. Elsayed, S., N. Hamilton, D. Boyd, and M. Mulvey. 2001. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J. Clin. Microbiol. 39:2367-2368.
5. Fluit, A. C., M. R. Visser, and F.-J. Schmitz. 2001. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14:836-871.
6. Gold, H. S. 2001. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin. Infect. Dis. 33:210-219.
7. Goossens, H., D. Jabes, R. Rossi, C. Lammens, G. Privitera, and P. Courvalin. 2003. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J. Antimicrob. Chemother. 51(Suppl. 3):iii5-iii12.
8. Jayaratne, P., and C. Rutherford. 1999. Detection of clinically relevant genotypes of vancomycin-resistant enterococci in nosocomial surveillance specimens by PCR. J. Clin. Microbiol. 37:2090-2092.
9. Kariyama, R., R. Mitsuhata, J. W. Chow, D. B. Clewell, and H. Kumon. 2000. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J. Clin. Microbiol. 38:3092-3095.
10. Klare, I., C. Konstabel, D. Badstubner, G. Werner, and W. Witte. 2003. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food Microbiol. 88:269-290.
11. Lu, J. J., C. L. Perng, T. S. Chiueh, S. Y. Lee, C. H. Chem, F. Y. Chang, C. C. Wang, and W. M. Chi. 2001. Detection and typing of vancomycin-resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR. Epidemiol. Infect. 126:357-363.
12. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing, 14th informational supplement, vol. 24, no. 1. NCCLS document M100-S14. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Palladino, S., I. D. Kay, J. P. Flexman, I. Boehm, A. M. G. Costa, E. J. Lambert, and K. J. Christiansen. 2003. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J. Clin. Microbiol. 41:2483-2486.
14. Patel, R., J. R. Uhl, P. Kohner, M. K. Hopkins, and F. R. Cockerill III. 1997. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J. Clin. Microbiol. 35:703-707.
15. Paule, S. M., W. E. Trick, F. C. Tenover, M. Lankford, S. Cunningham, V. Stosor, R. L. Cordell, and L. R. Peterson. 2003. Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 41:4805-4807.
16. Richter, E., M. Weizenegger, S. Rüsch-Gerdes, and S. Niemann. 2003. Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 41:2672-2675.
17. Roger, M., M.-C. Faucher, P. Forest, P. St-Antoine, and F. Coutlée. 1999. Evaluation of a vanA -specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak. J. Clin. Microbiol. 37:3348-3349.
18. Schouten, M. A., J. A. A. Hoogkamp-Korstanje, J. F. G. Meis, A. Voss, and the European VRE Study Group. 2000. Prevalence of vancomycin-resistant enterococci in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 19:816-822.
19. Werner, G., R. J. L. Willems, B. Hildebrandt, I. Klare, and W. Witte. 2003. Influence of transferable genetic determinants on the outcome of typing methods commonly used for Enterococcus faecium. J. Clin. Microbiol. 41:1499-1506.
20. Zhanel, G. G., N. M. Laing, K. A. Nichol, L. P. Palatnick, A. Noreddin, T. Hisanaga, J. L. Johnson, D. J. Hoban, and the NAVRESS Group. 2003. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J. Antimicrob. Chemother. 52:382-388.